Answers are grounded in this paper and cite their sources.
Cohort study reveals poorer prognosis for males with localized melanoma and type 2 diabetes, suggesting need for close follow-up.
T2D was associated with poorer prognosis among males with localised melanoma, whereas no prognostic impact was observed among females or patients with more advanced disease. These findings indicate the need for closer follow-up of males with early-stage melanoma and T2D, and for further studies to clarify underlying mechanisms and the potential benefits of optimised diabetes management.
No takes yet. Share an insight, caveat, or question.
Lyngstrand et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: